Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on transactions with securities and derivatives for the month of December 2025, filed on January 9, 2026. The report is submitted in compliance with Article 11 of CVM Instruction # 358/2002 regarding outstanding shares held in treasury.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on treasury share transactions.
| Metric | Value |
|---|---|
| Initial Treasury Balance (Common Shares) | 169,082,705 |
| Total Shares Delivered (Restricted) | 23,969,269 |
| Total Transaction Volume (R$) | 333,119,577.84 |
| Final Treasury Balance (Common Shares) | 145,113,436 |
Material Changes
The primary material change reported is a reduction in the company's treasury stock of common shares. During December 2025, Ambev S.A. executed four transactions involving the delivery of restricted shares directly with the company:
- Dec 01: 17,783,451 shares at R$ 13.86
- Dec 02: 135,174 shares at R$ 14.01
- Dec 14: 5,938,658 shares at R$ 14.02
- Dec 22: 111,986 shares at R$ 13.28
These transactions reduced the treasury balance from approximately 169.1 million shares to 145.1 million shares.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. The document is a statutory disclosure of specific share movements and contains no forward-looking statements.
Investor Verification Checklist
- Verify the impact of the 23.97 million share reduction on total outstanding shares and earnings per share (EPS) in the next quarterly report.
- Confirm the classification of these "restricted shares" and the vesting conditions associated with the delivery dates.
- Review the average transaction price (approx. R$ 13.90) against the prevailing market price for December 2025 to assess valuation.
- Check subsequent filings for any changes in the treasury balance or new buyback programs.